环胺在癌症治疗中的药基因组变异及其对生物活化和药理动学的影响
Ibrahim El-Serafi1,2, Sinclair Steele3
1Basic Medical Sciences Department College of Medicine Ajman University, Ajman, UAE.
概括
细胞染色体P450 (CYP) 2B6和其他酶的遗传变异显著影响循环胺 (Cy) 药物代谢和患者的结果. 了解这些复杂的相互作用是个性化剂量的关键.
科学领域:
- 药物基因组学 药物基因组学
- 药物新陈代谢 药物新陈代谢
- 瘤学 治疗学 治疗学
背景情况:
- 环胺 (Cy) 是一种关键的前药物,由细胞染色体P450 (CYP) 2B6.6广泛代谢.
- 包括CYP2B6在内的代谢酶的遗传多态性已经显示出对Cy动力学和临床疗效的有争议的影响.
- 多种酶,临床因素和药物相互作用的复杂相互作用使Cy的药理动力学复杂化.
研究的目的:
- 审查CYP2B6多态性对循环胺 (Cy) 动学的影响.
- 讨论其他酶,临床因素和影响Cy疗效和副作用的药物相互作用.
- 为个性化剂量策略提供Cy药物基因组学的全面摘要.
主要方法:
- 对CYP2B6多态性和Cy动力学研究的文献综述.
- 对之前报告的酶和影响Cy疗效的临床因素的分析.
- 关于药物相互作用的讨论,在Cy调节方案中以busulphan为例.
主要成果:
- CYP2B6多态性是Cy生物活化和动力学的重要决定因素.
- 多种相互作用的酶,患者年龄,诊断和同时服用的药物都会调节Cy的疗效.
- 了解Cy生物活化途径解释了其关键的副作用.
结论:
- 除了临床因素,CYP2B6和其他酶多态性,显著改变Cy动力学和患者的结果.
- 由于多因素的遗传和临床影响,精确量化Cy动力学是复杂的.
- 个性化 Cy 剂量策略根据药物基因组学可以优化治疗并改善临床结果.
相关概念视频
01:20Chronopharmacokinetics: Time-Dependent Pharmacokinetics
123
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
123
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:19Factors Affecting Drug Biotransformation: Biological
139
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
139
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:27Nonlinear Pharmacokinetics: Role of Transporters
47
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
47
01:25Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K